Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
| Last modified: | 01 July 2020 1.31 p.m. |
More news
-
25 July 2025
Article highlight: New insight in how cells regulate gene activity
A new study, led by University of Groningen molecular biologist Danny Incarnato, identifies hundreds of shapeshifting regulatory RNA switches in E.coli bacteria and human cells.
-
23 July 2025
Dutch astronomers in Tenerife to test high-speed camera
Astronomers from the University of Groningen and the University of Amsterdam are on the Canary Island of Tenerife until 29 July to test a special camera to detect gamma rays emitted by extreme objects, such as supermassive black holes and supernovae....
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...